awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55251007-82128C25-001A-4B47-8171-327374E7B34E
Q55251007-82128C25-001A-4B47-8171-327374E7B34E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55251007-82128C25-001A-4B47-8171-327374E7B34E
Usefulness of initial plasma dabigatran concentration to predict rebound after reversal.
P2860
Q55251007-82128C25-001A-4B47-8171-327374E7B34E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55251007-82128C25-001A-4B47-8171-327374E7B34E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e8dbf3ef4e71498285740adc8ceaf811d6d5ecf5
P2860
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment.